AKT1 and neoplasm: Recently, the anti-neoplastic effect of fasting was found to rely on glycogen synthase kinase 3β (GSK3β)8; fasting combined with hormone therapy effectively promotes long-lasting tumor regression and protects against drug resistance by suppressing AKT activation9.